Amy J. McMichael

Dec 11, 2024 | jamanetwork.com | Andrew Alexis |Amy J. McMichael |Tina Bhutani

Key PointsQuestion  Can innovative clinical trial design overcome barriers to recruiting and retaining participants with psoriasis and skin of color? Findings  This quality improvement study found that the VISIBLE trial achieved broad diversity among its approximately 200 participants through self-identification of race and ethnicity and inclusion of all skin types.

Dec 2, 2024 | hcplive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

OpinionVideoDecember 2, 2024Author(s):, JAK inhibitors provide targeted treatment for alopecia by modulating immune pathways, offering a promising therapeutic option. Patient-specific factors, such as disease severity and comorbidities, should guide the selection of JAK inhibitors. Monitoring for potential side effects, including infections and hematologic abnormalities, is crucial in JAK inhibitor therapy. Collaboration with dermatologists can enhance treatment outcomes in alopecia management.

Dec 2, 2024 | consultantlive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

Dec 2, 2024 | consultantlive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

Dec 2, 2024 | hcplive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

OpinionVideoDecember 2, 2024Author(s):, Healthcare providers are essential in educating patients about alopecia's early signs and treatment options, promoting awareness and understanding. Integrating alopecia discussions into routine check-ups and using educational materials can effectively inform patients about the condition. Emphasizing early diagnosis and intervention can lead to more effective management of alopecia, improving patient outcomes.